|

Application of [68Ga]Ga-NI-FAPI-04 PET/CT Imaging in Fibroblast Activation Protein Related Diseases

RECRUITINGPhase 1/2Sponsored by Peking Union Medical College Hospital
Actively Recruiting
PhasePhase 1/2
SponsorPeking Union Medical College Hospital
Started2025-12-17
Est. completion2027-02-17
Eligibility
Age18 Years – 85 Years
Healthy vol.Accepted
View on ClinicalTrials.gov →

NCT07464132

Summary

The purpose of this study is to conduct clinical research on \[68Ga\] Ga-NI-FAPI-04 PET/CT imaging and further investigate its diagnostic value in fibroblast activation related diseases.

Eligibility

Age: 18 Years – 85 YearsHealthy volunteers accepted
Inclusion Criteria:

* 1: 18-85 years old

  2: Tumor patients can undergo surgery or biopsy to obtain pathological diagnosis

  3: Ability to understand and sign informed consent forms

  4: Expected survival period exceeding 6 months and able to receive follow-up

  5: Healthy volunteers without chronic medical history of hypertension, diabetes, coronary heart disease, kidney disease, tumor, etc

Exclusion Criteria:

* 1: Pregnant or lactating women

  2: Patients allergic to research drug ingredients

  3: Patients with severe liver and kidney dysfunction (blood creatinine levels exceeding 159 μ mol/L)

  4: Patients who participate in other clinical trials and interfere with the results of this study

  5: Patients with severe illness who cannot cooperate with the examination

Conditions9

CancerCardiovascular DiseasesHeart DiseaseHypertrophic Cardiomyopathy (HCM)Lung CancerOther Hypoxic and Fibroblast Activated DiseasesPulmonary FibrosisRheumatic Immune Diseases Involving Large Blood VesselsTumor

Interventions1

Injection of 68Ga-NI-FAPI

Browse More Trials

Cancer trialsHeart Disease trialsLung Cancer trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.